Agarwal R, Green JB, Heerspink HJL, Mann JFE, et al. COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics. Nephrol Dial Transplant 2025 Feb 7:gfaf022. doi: 10.1093.
PMID: 39916475